AL208
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL208, covering 2012-10-24 to 2012-10-24. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery [Phase 2]